OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
For list of speakers and registration, visit chembiohub.ox.ac.uk/conversation
This event showcases top chemical biology research from labs at Oxford. Particular emphasis is placed on linking basic chemical biology research to work in the clinic.
The first session of the day looks at disease-agnostic technologies to aid drug discovery. The second session features work on targets and pathways applied to a variety of illnesses. The third session focuses on therapeutic interventions for neurodegenerative diseases.
Each session features top-class science presentations from a broad range of Oxford’s biomedical and physical science departments, with speakers from industry giving their perspective throughout the day. This sets the stage for a round-table discussion between opinion leaders from across Oxford and industry. The conversation will focus on how we can best work together to translate ideas into new medicines.
The symposium will bring together 200 delegates including Oxford researchers, industry colleagues and technology transfer professionals. In doing so, it will provide the ideal forum for discussion and lead to lasting collaborative relationships.
Networking breaks and poster sessions will allow discussion to continue outside of the lecture theatre. The day will finish with a wine reception in the common room of the Andrew Wiles building, which provides a beautiful view of the 18th century Radcliffe Observatory.
